Skip to content

Clinical trials

Phase 4 Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 4 Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20043
20082
20095
20101
20116
20124
20137
20145
20153
20162
20174
20182
20193
20204
20214
20225
20235
20244
202510
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Not yet recruiting18
Recruiting15
Unknown status7
Terminated5
Active, not recruiting4
Enrolling by invitation3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
InQpharm Group3
Eisai Inc.2
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz2
Instituto de Investigación Hospital Universitario La Paz2
Laval University2
RenJi Hospital2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
University of Miami2
University of Pennsylvania2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight107
Obesity91
Diabetes Mellitus, Type 221
Weight Loss15
Body Weight7
Diabetes Mellitus7
Hypertension5
Insulin Resistance5
Prediabetic State5
Cardiovascular Diseases4

Trials

Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.